New Trials in Leukemia and Lymphoma: Could Your Patient Benefit?February 28, 2024PediatricsPatient & Survivor CareB Cell LymphomaCLLMixed TopicsALL
Doxorubicin Increases Breast Cancer Risk in Women With Hodgkin LymphomaFebruary 27, 2024Patient & Survivor CareHodgkin Lymphoma
Are Food Emulsifiers Associated With Increased Cancer Risk?February 23, 2024Patient & Survivor CareDLBCLAggressive LymphomasALLAMLB Cell LymphomaCLL
Democratic Lawmakers Press Pfizer on Chemotherapy Drug ShortagesFebruary 22, 2024DLBCLMixed TopicsPatient & Survivor CareAggressive LymphomasALLAMLBleeding Disorders
Unleashing Our Immune Response to Quash CancerFebruary 21, 2024Gene TherapyMixed TopicsPatient & Survivor CarePediatricsAggressive LymphomasALLAML
Dana-Farber Moves to Retract, Correct Dozens of Cancer Papers Amid AllegationsJanuary 25, 2024Patient & Survivor CareBusiness of Medicine
Oncologists Sound the Alarm About Rise of White BaggingJanuary 18, 2024Patient & Survivor CareMixed TopicsBusiness of Medicine
CHP/CCUS: Low blood cancer risk for most patientsSeptember 8, 2023Mixed TopicsMyelodysplastic SyndromeAnemiaThrombosisPatient & Survivor CareBleeding Disorders
Medicare announces 10 drugs targeted for price cuts in 2026August 30, 2023Business of MedicinePatient & Survivor CareThrombosis
Multiprong strategy makes clinical trials less WhiteJune 23, 2023Diversity in MedicinePatient & Survivor CareDLBCLALLAggressive LymphomasAMLB Cell Lymphoma
CBSM phone app eases anxiety, depression in cancer patientsJune 23, 2023Patient & Survivor CareDLBCLAggressive LymphomasALLAMLCLLCML
Huge underuse of germline testing for cancer patientsJune 22, 2023Patient & Survivor CareDLBCLAggressive LymphomasALLAMLB Cell LymphomaCellular Therapy
Drugmakers are abandoning cheap generics, and now U.S. cancer patients can’t get medsJune 22, 2023Patient & Survivor CareDLBCLAggressive LymphomasALLAMLAnemiaB Cell Lymphoma
Cancer drug shortages spur worry, rationing, and tough choicesJune 16, 2023Patient & Survivor CareDLBCLMixed TopicsCLL
Widespread carboplatin, cisplatin shortages: NCCN surveyJune 9, 2023Patient & Survivor CareMixed TopicsAggressive LymphomasALLAMLB Cell LymphomaCLL
